Jakub Svoboda
Hospital of the University of Pennsylvania
ORCID: 0000-0002-6359-7065Also affiliated with UPMC Hillman Cancer Center, University of Pennsylvania
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 8 papers. Top paper: “Ipilimumab, nivolumab, and brentuximab vedotin combination therapies in patients with relapsed or refractory Hodgkin lymphoma: phase 1 results of an open-label, multicentre, phase 1/2 trial”.
Fangxin Hong, Richard F. Ambinder, Jonathon B. Cohen, Michael J. Robertson, Kevin A. David +12 more
Vincent A. LoRe, Anthony R. Mato, Elise A. Chong, Jacqueline C. Barrientos, James N. Gerson +7 more
Luca Castagna, Laura Giordano, Vincent T. Ho, Paolo Corradini, Anna Guidetti +61 more
Hatcher J. Ballard, Austin R. Pantel, Esin C. Namoglu, Mitchell E. Hughes, Sunita D. Nasta +7 more
Kingsley Gideon Kumashie, Emeline R. Chong, Joseph Fabrizio, Aditi Gupta, Jakub Svoboda +38 more
Luca Paruzzo, Vrutti Patel, Jakub Svoboda, Emeline R. Chong, Eugenio Fardella +15 more
Kingsley Gideon Kumashie, Emeline R. Chong, Joseph Fabrizio, Aditi Gupta, Jakub Svoboda +38 more
Fredrik Ellin, Thomas Relander, Miao Cao, Wenrui Li, Qi Long +46 more